On-prem, single-tenant private-cloud, or customer-managed AWS-hosted MES with a containerized, microservices-capable framework — semiconductor- and electronics-native, extended into medical devices, with thin pharma-specific footprint.
Critical Manufacturing (founded 2009 in Porto, Portugal by ex-Siemens/Infineon/Qimonda semiconductor manufacturing-IT engineers; acquired by ASMPT in 2018) ships a modular MES platform delivered as a single suite — there is no separately branded pharma edition and no pharma vertical on the company's industry navigation. Declared verticals are Semiconductor, Electronics, Medical Devices, and Industrial Equipment. Pharma and biotech are addressed indirectly through (a) the Medical Devices vertical, (b) partner-led implementations (FrontWell Solutions, Dataworks, Arcondis, Cognizant), and (c) thought-leadership blog content.
The platform is built on the Microsoft stack (.NET, SQL Server) with a three-tier architecture, packaged as the "Critical Manufacturing Framework," and delivered through containerized services (Red Hat OpenShift partnership; AWS deployment guidance published by AWS). Recipe semantics are based on SEMI E139 (semiconductor recipe standard), not ISA-88 batch-process semantics. Current major release is V11 (V10 was the 2023 "new standard").
Gartner classified Critical Manufacturing as a Leader in the Magic Quadrant for MES in 2021, 2022, and 2023 (three consecutive years); the MQ was discontinued thereafter and the vendor is now a Representative Vendor in the 2025/2026 Gartner Market Guide for MES. IDC named it a Leader in the IDC MarketScape: Worldwide MES 2024–2025; Frost & Sullivan placed it on the Frost Radar for MES 2024.
Critical Manufacturing is semiconductor- and electronics-native, extended into medical devices, and reaches into pharma only via partner services. The vendor publishes no pharma-specific edition, no pharma master batch record (MBR) accelerators, no Annex 11 / ICH Q9/Q10 / ISO certifications statements, and no named pharmaceutical drug-substance or drug-product customer.
Core Capabilities
FDA & GxP Compliance
Data Integrity & Validation
Three-tier architecture (presentation, business services, data and analytics) on Microsoft .NET with SQL Server backend, packaged as the Critical Manufacturing Framework. Container-based microservices delivery via Red Hat OpenShift with CI/CD and daily containerised deployments since V10 (2023). Deployment options: on-premises, single-tenant private cloud, or customer-managed public cloud (AWS deployment guidance published by AWS). Not multi-tenant SaaS.
Browser-based responsive UI; mobile/tablet via web app and AR module (no confirmed native iOS/Android client). REST APIs across all services; native SAP IDoc/BAPI/RFC; SSIS ETL. Data standards: SEMI E10, SEMI E139, OPC-UA, OPC-DA, SECS/GEM, IPC-CFX, MQTT; ISA-95 referenced architecturally. ISA-88, B2MML, HL7, GS1, EPCIS native conformance: not publicly stated. SSO certification specifics, GraphQL, webhooks, and pre-built Veeva/Workday/LabWare connectors: not publicly stated. Data residency is customer-determined.
Reported as tiered per-user licensing (view-only, limited, full-user) plus annual support, with perpetual or subscription terms negotiated. No public pricing transparency — all deals are enterprise-quoted; no starting price on Capterra, SelectHub, FitGap, or vendor site. No free trial; demos arranged via "Schedule a demo" form. Third-party reviewers characterise pricing as "enterprise positioning … prohibitive for small to mid-sized manufacturers." Reported deal sizes by customer segment, minimum commitments, setup fees, and validation-support fees: not publicly disclosed.
Vendor does not publish typical implementation durations. Public anchors include Elekta (three sites — Netherlands, UK, China — rolling expansion since 2017), a 24-month implementation at a vertically integrated dental medical-device manufacturer (askcraig.ai case study), and B. Braun Medical Industries Penang (initial implementation 2017; selected as global discrete-manufacturing standard in November 2021). No public reference exists for a biotech or top-20 pharma implementation.
Implementation services are not bundled in license — delivered by Critical Manufacturing professional services or partners (Cognizant, Arcondis, RoviSys, FrontWell Solutions, Dataworks, Athena, Strategic Information Group). Validation is typically partner-led (Dataworks explicitly positions validation services). Common pitfalls (per third-party reviewers): MES modeling is a specialised skill requiring up to six months of training; part-time team participation during core development is a frequent failure mode; configuration depth can outpace organisational maturity and produce scope creep.
PharmaSpotter assessment from published vendor and third-party sources. No user reviews are on file for this product.
Strengths
Users praise platform flexibility and configurability ("flexible enough to be customized for all of our SKUs … but also locked tight enough to pass our internal and external compliance audits"), agile/multi-environment project delivery ("development for testing, stage validation, and production versions"), real-time production monitoring, and ease of creating new product flows (Elekta MES champion: new-product setup reduced from "20 hours over a few months to five hours within one day"). The R&D roadmap (container deployment, AR, digital twin, AI copilots) is also frequently cited.
Limitations & Open Questions
Users report initial setup complexity for less-technical employees, that MES modeling is a specialised skill requiring up to six months of training, that part-time team participation during implementation is a common failure mode, and that significant upfront investment and external consulting expertise are required. Configuration depth can outpace organisational maturity and produce scope creep. Third-party reviewers describe the platform as "Swiss Army knife"–wide but resource-intensive.
Help the community
Share your experience with Critical Manufacturing MES anonymously. Your insights help pharmaceutical professionals make better software decisions.
Contribute Anonymous FeedbackPublicly disclosed pharmaceutical and biotech organizations
Jump to section